Patent for HIV drug rejected, paves way for entry of generics | India News – Times of India
NEW DELHI: The Indian Patent Office has rejected the grant of a patent for dolutegravir, a crucial HIV drug marketed by Viiv Healthcare, facilitating the entry of generics and expanding access to affordable, life-saving treatment. The decision, announced after a contentious nearly decade-long battle, follows the company’s patent application for the HIV treatment in 2007.The…